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Background: Breast adenomyoepithelioma is an unusual tumor characterized by a biphasic proliferation of
epithelial and myoepithelial cells. Most breast adenomyoepitheliomas are considered to be benign or to have a
low-grade malignant potential, characterized by propensity for local recurrence. Malignant changes arising in this
lesion are extremely rare and may involve one or both cellular components.
Case report: We discuss a case of a 60 year-old woman who began to experience pain in her right breast in
January 2009. Breast ultrasound and mammography were performed showing a rounded, hypoechoic solid lesion
with ill-defined margins in the right inner-inferior quadrant, suspicious of malignancy. Quadrantectomy of the inner-
inferior quadrant of the right breast with sampling of ipsilateral axillary lymph nodes was performed. The
histological analysis confirmed the diagnosis of adenomyoepithelioma with focal malignant change of the epithelial
component, associated with high-grade malignant myoepithelial change. The patient was treated with adjuvant
radiotherapy and her right breast received a dose of Gy 50 with a boost of Gy 10 to the tumor bed. At present, the
patient shows no sign of tumor recurrence.
Conclusion: Breast malignant adenomyoepithelioma is a rare tumor which should be considered in the differential
diagnosis of other solid breast lesions. Only few cases have been reported in the literature. Diagnosis, optimal
therapy and predicting the outcome are problematic issues due to the rarity of this disease which appears to have
hematogenous rather than lymphatic spread and usually occurs in primary tumors ≥ 1.6 cm in size.
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Proliferative lesions of the mammary gland arise mainly
in the terminal duct lobular unit (TDLU). Most lesions
exhibit epithelial alterations; however, some mammary
lesions show myoepithelial changes [1]. Myoepithelial
basal cells are localized between luminal epithelial cells
and the stroma, which place them in an ideal position in
order to communicate with both compartments. The
myoepithelial cells express typical cytokeratins of the basal
layer of stratified epithelia (CK5, CK14, and CK17), fila-
mentous α-smooth muscle actin (SMA) and the heavy* Correspondence: natale.porta@alice.it
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reproduction in any medium, provided the orchain-myosin (hc-myosin). Some tumor suppressor pro-
teins, including p63, p73, 14-3-3 sigma, maspin and
Wilms Tumor (WT-1) have been preferentially detected
in myoepithelial cells [2]. Recent data indicate the exist-
ence of a morphologically distinct myoepithelial cell,
which lacks expression of SMA and in some cases also
lacks CK5, CK14, and CK17 [3], indicating that a hier-
archical differentiation pattern may exist within the
myoepithelial lineage. Myoepithelial cells rarely trans-
form; however, when they do transform, they generally
give rise to benign or low-grade malignant tumors. The
lesions which show a myoepithelial component are rare
in the mammary gland, and they are often benign and
biphasic, with an epithelial and a myoepithelial basal
component [1]. The adenomyoepithelioma is a biphasicl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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which can be found in salivary gland, skin adnexal and
lung, but is more frequent in the mammary gland. This
entity rarely progresses to a more malignant state or gives
rise to metastasis [1]. Morphological features of malig-
nancy that could predict the potential for local recurrence
and/or metastasis are not well-established. The likelihood
of recurrence seems to be associated with incomplete
removal [4], cellular pleomorphism, mitoses, necrosis,
invasion of the surrounding tissue and association with
other types of malignant tumors such as invasive ductal
carcinoma and undifferentiated carcinoma [5]. The classi-
fication of the World Health Organization (WHO, 2012)
divides the adenomyoepithelioma into a benign type
where both the epithelial and myoepithelial component
are histologically non-malignant and a form which shows
a malignant transformation [6]. Although rare, this malig-
nant transformation can develop from one of the two
components, epithelial and myoepithelial, or from both.
This case of malignant adenomyoepithelioma is of interest
not only for its rarity, but also for the peculiar aspects
of the malignant component that in some areas shows
morphological and immunophenotypical similarities to
basal-like breast carcinoma.
Case presentation
We describe a 60 year-old female patients, of Caucasian
origin, in generally good health (PS = 0), with no family
history of cancer. In January 2009, the patient developedFigure 1 Radiological characteristics of lesion; (A and B) mammograp
breast show an ill-defined end opacity in the inner-inferior quadrant
breast shows a hypoechoic nodule of about 17 mm diameter aroundpain in the right mammary region. The onset of this pain
was initially attributed to a trauma she had had in this
area. The patient underwent several clinical examinations
which included echography of both mammary glands and
corresponding axillary cavities. The ultrasonography high-
lighted an oval shaped hypoechoic mass of about 17 mm
around the right mammary region near the areola, on the
border between superior and internal-inferior quadrants
(Figure 1). The mammography confirmed the presence of
this nodular lesion which was about 20 mm (Figure 1).
After the radiological examinations, a fine needle aspir-
ation of the lesion was performed. The sample taken was
not diagnostic. After surgical videat, lumpectomy around
the areola was performed on the patient. The histological
analysis of the mammary lumpectomy revealed an adeno-
myoepithelioma with focal malignant transformation of
the epithelial component (2.4 mm) and a more spread ma-
lignant transformation of the myoepithelial component
(12 mm) without necrosis and metastasis in the lymph
nodes (Figures 2 and 3). The surgical margin was free (dis-
tance over 2 cm). For the clinical staging, the patient
underwent a chest X-ray, echography of the liver and a
bone scan. All the examinations were negative. The right
mammary gland of the patient was treated with radiother-
apy (gray (Gy) 50 total dose plus a boost of Gy 10 to the
tumor bed). At present, the patient shows no signs of
tumor recurrence. The histological report describes a le-
sion with multilobulated outlines, pushing margins and bi-
phasic aspects due to the presence of a double populationhy craniocaudal and mediolateral oblique views of the right
of about 20 mm diameter; (C): ultrasonography of the right
the right mammary region near the areola.
Figure 2 Morphological characteristics of the lesion; (A) the lesion shows multilobulated outlines and pushing margins (hematoxylin-
eosin, magnification 4×); (B) the benign component is composed of rounded or elongated tubules lined by a single layer of epithelial
cells and one or two layers of myoepithelial cells (hematoxylin-eosin, magnification 40); (C) the malignant component shows
cytological atypia of epithelial and myoepithelial components (hematoxylin-eosin, magnification 40×).
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with an oval-shaped nucleus, minute nucleolus and eo-
sinophilic cytoplasm with sharp margins (epithelial-like
component). These cells are arranged in glandular-like
structures, distorted and compressed by elongated cells
with clear cytoplasm (myoepithelial-like component).
This second population of cells is more abundant in
number. The epithelial-like component shows an aver-
age proliferative index of three mitoses for ten high
power fields. However, there is a focal area (in the sec-
tion) of 2.4 mm of highly atypical epithelioid cellsFigure 3 Immunohistochemical characteristics of the lesion; (A) expre
(magnification 10×); (C) expression of CK 5 (magnification 10×); (D) earranged in sheets and clumps with features of stromal
infiltration. In this area, the epithelioid cells show an
average proliferative index of seven mitoses for ten high
power fields. The myoepithelial-like component, present
in larger quantities, shows in part (12 mm in diameter)
histologically malignant aspects due to the presence of
atypical cells and an average proliferative index of 32 mi-
toses for 10 high power fields. An immunohistochemical
study was then carried out using the following antibodies:
cytokeratin 5 (clone XM26 Novocastra Leica Biosystems),
cytokeratin 6 (clone LHK6B Novocastra Leica Biosystems),ssion of CK 7 (magnification 10×); (B) expression of p63
xpression of S-100 (magnification 10×).
Table 1 Immunohistochemical results
VIM CK5 CK6 CK7 CK8/18 CK14 CK19 P63 S100 CD10 ER PG HER-2
EM - −/+ + + - + - −/+ −/+ - -−/+ - -
EB - −/+ −/+ + −/+ + −/+ - - - −/+ −/+ −/+
MM + - + −/+ - - - + + + -−/+ - -
MB + −/+ + −/+ - - - + + + -−/+ - -
Legend:
EM, epithelial malignant component.
EB, epithelial benign component.
MM, myoepithelial malignant component.
MB myoepithelial benign component.
negative (−) antibody was not found in any cell.
largely positive (+) > 75% of the cells were positive.
locally positive (−/+) 25 to 75% of the cells were positive.
focally positive (−/+) < 25% of the cells were positive.
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Biosystems), cytokeratin 8/18 (clone 5D3 Novocastra Leica
Biosystems), cytokeratin 14 (clone LL002 Novocastra
Leica Biosystems), cytokeratin 19 (clone B170 Novocastra
Leica Biosystems), estrogen receptors (clone 6F11 Novo-
castra Leica Biosystems), progesterone receptors (clone 16
Novocastra Leica Biosystems), HER-2 (HercepTest DAKO),
p53 (clone DO7 Novocastra Leica Biosystems), p63 (clone
7JUL Novocastra Leica Biosystems), CD10 (clone 56C6
Novocastra Leica Biosystems), e-cadherin (clone 36B5
Novocastra Leica Biosystems), vimentin (clone V9 Novo-
castra Leica Biosystems) and S100 (clone S100 Novocastra
Leica Biosystems). The immunohistochemical reactions
were evaluated with a semiquantitative method. The
cellular proliferative index was evaluated by Ki-67
(clone MM1 Novocastra) and showed 10% of nuclear
cellular positivity. The immunohistochemical analysis
showed the epithelial luminal nature of the epithelioidTable 2 Malignant epithelial and myoepithelial adenomyoepi
First author Age (years)/sex Size (cm) Early treatment
Bult [4] 52/F 1.6 Radical modified m
Kihara [19] 86/F 4.0 × 3.5 × 3.5 Simplex mastectom
Loose [20] 42/F 3.5 × 3 × 2 Excisional biopsy
Nadelman [8] 46/F not described Lumpectomy
Nadelman [8] 73/F not described Not performed
Rasbridge [21] 76/F 15 Extensive local excis
Takahashi [22] 60/F 9 × 8 × 6 Radical mastectomy
Trojani [23] 51/F 2 Excisional biopsy
Chen [24] 47/F 17 × 11 × 6 Radical modified m
Jones [9] 71/F 3 × 3 × 2 Mastectomy with ly
Foschini [10] 60/F 4 Lumpectomy
Legend: F, female; Y, years; M, months; W, weeks.benign component because this component was positive
for luminal cytokeratins (7, 8/18, 19) (Table 1). The ma-
lignant epithelioid component of the lesion was largely
positive for luminal cytokeratin 7 and locally positive
for myoepithelial-basal markers (p63, S100, cytokeratins
5, 6, 14) (Table 1). The elongated benign and malignant
cells of the lesion gave a positive result with all
myoepithelial-basal markers (Table 1).
Discussion
The adenomyoepithelioma of the breast is uncommon,
often benign or with low potential of malignancy or local
recurrence. Metastases arising from malignant variants
of such tumors also occur rarely although several such
cases have been reported [7]. Review of the literature re-
veals that malignant lesions appear to fall into two broad
groups: those that are readily identified as consisting of
areas of obvious malignancy arising in conjunction withthelioma of the breast with metastases: meta-analysis
Metastasis after early treatment
astectomy 12Y thyroid









24M lung, bone, mediastinal lymph nodes
2Y lung
astectomy 3W bone
mphadenectomy 2Y liver on autopsy
21M lung
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with the overall appearance of an adenomyoepithelioma
but seen on close examination to contain foci of cellular
atypia and increased mitotic activity. Recurrent tumors
and distant metastases have been reported in association
of both groups. Among the 11 cases of either epithelial
and myoepithelial changes included in these studies
[7,8], two cases showed malignant transformation of the
myoepithelial component only [1,9] and one cases
showed malignant transformation of the epithelial com-
ponent only [10] (Table 2). Because of the capacity of
adenomyoepithelioma with both epithelial and myoe-
pithelial malignant transformation to metastasize, this
entity should preferably be treated by wide local excision
with appropriate margins [7]. The presence of metasta-
ses was described in patients with a tumor of ≥ about
1.6 cm. The metastases spread mainly via the blood sys-
tem, with brain and lungs as main target organs. How-
ever, there are no data about sentinel lymph node
removal and/or lymphadenectomy and the adjuvant
radiotherapy and/or chemotherapy. The genesis of infil-
trating breast cancer today is considered to be a complex
process with several phases that originates from stem
cells of the terminal duct lobular unit (TDLU) [11]. The
identification of adult stem cells in the mammary tissue
in the TDLU, that are able to differentiate themselves
initially into epithelial glandular precursor cells (CK5
and CK8/18 positive), or into precursor cells of the
myoepithelial layer (CK5 and SMA positive) and, subse-
quently, into mature luminal cells (CK8/18 positive)
and mature myoepithelial cells [12,13] (SMA positive),
confirmed the distinction of the breast cancer in lu-
minal, basal, HER-2 positive and ‘similar to normal’
breast highlighted by gene expression studies [14,15].
Nielsen et al. proposed a panel composed of immuno-
histochemical markers anti-ER, anti-EGFR, anti-HER2,
and anti-CK 5/6 to identify basal breast cancer [16]. In
our case, the epithelioid malignant component revealed
a widespread expression of the epithelial luminal CK7
marker together with expression of the ‘staminal’ CK5
marker and the myoepithelial p63 and S-100 markers
which could suggest that the origin of this component is
from the stem cells of the mammary gland with an inter-
mediate epithelial-mesenchymal differentiation. Reis-Filho
et al. showed a basal-like immunophenotype (ER-, HER2-,
EGFR + and/or CK5/6 +) in 59 out of 65 cases of meta-
plastic breast cancer that produces stromal matrix that
is an epithelial carcinoma with areas of mesenchymal
differentiation [17]. Futhermore, a case of malignant
adenomyoepithelioma of the breast that produces stromal
matrix was described with immunohistochemical profile
of myoepithelial differentiation (S100 e maspin positive)
but not basal-like (CK14-negative) in the metaplastic com-
ponent [18]. The presence of neoplastic components withan intermediate epithelial-mesenchymal differentiation in
biphasic tumors of mammary gland suggests that these
lesions can originate from mammarian stem cells with the
potential to differentiate themselves into epithelial or into
mesenchymal-myoepithelial cells.Conclusion
Breast malignant adenomyoepithelioma is a rare tumor
which should be considered in the differential diagnosis
of other solid breast lesions. Only a few cases have been
reported in the literature and establishing the diagnosis,
determining the optimal therapy as well as predicting
the outcome are problematic issues due to the rarity of
this disease. The adenomyoepithelioma appears to have
hematogenous rather than lymphatic spread and usually
occurs in primary tumors ≥ 1.6 cm in size.Consent
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